Winston Ueno

784 total citations
13 papers, 531 citations indexed

About

Winston Ueno is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Winston Ueno has authored 13 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Winston Ueno's work include Cancer Treatment and Pharmacology (3 papers), Metastasis and carcinoma case studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Winston Ueno is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Metastasis and carcinoma case studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Winston Ueno collaborates with scholars based in United States and Vietnam. Winston Ueno's co-authors include Philip S. Schein, Paul V. Woolley, John S. Macdonald, Robert M. Goldberg, James D. Ahlgren, Daniel F. Hoth, Frederick P. Smith, Patrick J. Byrne, R. Timothy Webb and Shuli Silberman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Winston Ueno

12 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Winston Ueno United States 8 265 197 120 113 96 13 531
S T O’Dwyer United Kingdom 11 215 0.8× 227 1.2× 74 0.6× 92 0.8× 67 0.7× 18 554
De Haas Netherlands 9 164 0.6× 170 0.9× 62 0.5× 68 0.6× 59 0.6× 19 562
Daniel G. Miller United States 11 220 0.8× 92 0.5× 65 0.5× 74 0.7× 176 1.8× 23 661
Toshiki Kamano Japan 12 259 1.0× 261 1.3× 65 0.5× 120 1.1× 66 0.7× 108 534
Nicoletta Ravarino Italy 11 244 0.9× 142 0.7× 47 0.4× 82 0.7× 68 0.7× 25 517
Å Rimsten Sweden 14 352 1.3× 93 0.5× 201 1.7× 36 0.3× 164 1.7× 34 609
Κonstantinos Romanidis Greece 13 237 0.9× 175 0.9× 79 0.7× 164 1.5× 45 0.5× 55 594
Grant N. Stemmerman United States 8 338 1.3× 191 1.0× 65 0.5× 151 1.3× 224 2.3× 12 633
Cari L. Meinhold United States 9 207 0.8× 81 0.4× 85 0.7× 109 1.0× 29 0.3× 10 483
Marvin A. Jackson United States 9 84 0.3× 83 0.4× 89 0.7× 226 2.0× 45 0.5× 14 485

Countries citing papers authored by Winston Ueno

Since Specialization
Citations

This map shows the geographic impact of Winston Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winston Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winston Ueno more than expected).

Fields of papers citing papers by Winston Ueno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winston Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winston Ueno. The network helps show where Winston Ueno may publish in the future.

Co-authorship network of co-authors of Winston Ueno

This figure shows the co-authorship network connecting the top 25 collaborators of Winston Ueno. A scholar is included among the top collaborators of Winston Ueno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winston Ueno. Winston Ueno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ueno, Winston & Roy Beveridge. (2005). Time Burden of Blood Transfusion.. Blood. 106(11). 3125–3125. 3 indexed citations
2.
Hesketh, Paul J., et al.. (1999). Randomized Phase II Study of the Neurokinin 1 Receptor Antagonist CJ-11,974 in the Control of Cisplatin-Induced Emesis. Journal of Clinical Oncology. 17(1). 338–338. 86 indexed citations
3.
Ahlgren, James D., Neil M. Ellison, Jacob J. Lokich, et al.. (1993). Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.. Journal of Clinical Oncology. 11(10). 1957–1968. 90 indexed citations
4.
Miller, John A., T. Butler, Roy Beveridge, et al.. (1993). Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.. PubMed. 15(3). 486–99. 19 indexed citations
5.
Raschko, James, Elizabeth A. Johnson, Winston Ueno, Paul V. Woolley, & Joseph Treat. (1991). Continuous Infusion 5-Fluorouracil with Bolus Adriamycin and Mitomycin and Low-Dose Cisplatin (FAMP) in the Treatment of Metastatic Gastric Carcinoma: An Evaluation of Efficacy and Toxicity. Cancer Investigation. 9(1). 49–51. 4 indexed citations
6.
Edwards, Barbara & Winston Ueno. (1991). Sedation Before Ventilator Withdrawal. The Journal of Clinical Ethics. 2(2). 118–122. 5 indexed citations
7.
Goldberg, Robert M., Frederick P. Smith, Winston Ueno, James D. Ahlgren, & Philip S. Schein. (1986). 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.. Journal of Clinical Oncology. 4(3). 395–399. 56 indexed citations
8.
Stefanik, Danuta, Robert M. Goldberg, Patrick J. Byrne, et al.. (1985). Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer.. Journal of Clinical Oncology. 3(5). 660–665. 89 indexed citations
9.
España, Pilar, et al.. (1984). Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck. Cancer Chemotherapy and Pharmacology. 12(2). 98–100. 4 indexed citations
10.
Harris, Michael A., et al.. (1984). Treatment of advanced breast cancer with two doxorubicin-containing regimens. American Journal of Clinical Oncology. 7(1). 51–58. 7 indexed citations
11.
Macdonald, John S., et al.. (1979). 5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer. Cancer. 44(1). 42–47. 83 indexed citations
12.
Woolley, Paul V., et al.. (1978). Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer. 41(2). 387–391. 85 indexed citations
13.
Ueno, Winston, et al.. (1977). Streptozotocin (Strep), mitomycin C (MMC) and 5 fluorouracil (5 FU), SMF, chemotherapy for advanced pancreatic carcinoma: phase II trial. 18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S T O’Dwyer Breakdown of academic impact, for papers by De Haas Breakdown of academic impact, for papers by Daniel G. Miller Breakdown of academic impact, for papers by Toshiki Kamano Breakdown of academic impact, for papers by Nicoletta Ravarino Breakdown of academic impact, for papers by Å Rimsten Breakdown of academic impact, for papers by Κonstantinos Romanidis Breakdown of academic impact, for papers by Grant N. Stemmerman Breakdown of academic impact, for papers by Cari L. Meinhold Breakdown of academic impact, for papers by Marvin A. Jackson
Rankless by CCL
2026